NRAS and BRAF mutations in atypical melanocytic lesions arising in melanoma patients treated with vemurafenib

被引：0
|
作者：
Chu, Emily Y.
Wilson, Melissa
Sobanko, Joseph
Miller, Christopher
Suh, EunRan
Xu, Wei
Letrero, Richard
Elenitsas, Rosalie
Karakousis, Giorgos
Xu, Xiao Wei
Elder, David
Amaravadi, Ravi K.
Schuchter, Lynn Mara
Nathanson, Katherine L.
机构：
[1] Hosp Univ Penn, Philadelphia, PA 19104 USA
[2] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA
[3] Univ Penn, Philadelphia, PA 19104 USA
[4] Univ Penn, Sch Med, Philadelphia, PA 19104 USA
[5] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9017
引用
收藏
页数：1
相关论文
共 50 条
  • [41] The combination of mutations in BRAF and NRAS genes within a one tumor in patients with cutaneous melanoma
    Aksenenko, M. B.
    Anton, Avershuk S.
    Ruksha, T. G.
    BYULLETEN SIBIRSKOY MEDITSINY, 2019, 18 (03): : 226 - 231
  • [42] Association between TERT promoter mutations and BRAF/NRAS mutations in patients with primary and metastatic melanoma tumors
    Chang, Gregory A.
    Tadepalli, Jyothirmayee S.
    Fleming, Nathaniel H.
    Lui, Kevin
    Shao, Yongzhao
    Darvishian, Farbod
    Pavlick, Anna
    Berman, Russell
    Shapiro, Richard
    Osman, Iman
    Polsky, David
    CANCER RESEARCH, 2015, 75
  • [43] Prevalence of BRAF and NRAS Mutations and a Comparative Analysis in Primary and Metastatic Melanoma of Korean Patients
    Choi, Deok Young
    Lee, Sang Pyo
    Park, Sanghui
    EWHA MEDICAL JOURNAL, 2014, 37 (01): : 30 - 35
  • [44] Impact of NRAS Mutations for Patients with Advanced Melanoma Treated with Immune Therapies
    Johnson, Douglas B.
    Lovly, Christine M.
    Flavin, Marisa
    Panageas, Katherine S.
    Ayers, Gregory D.
    Zhao, Zhiguo
    Iams, Wade T.
    Colgan, Marta
    DeNoble, Sarah
    Terry, Charles R.
    Berry, Elizabeth G.
    Iafrate, A. John
    Sullivan, Ryan J.
    Carvajal, Richard D.
    Sosman, Jeffrey A.
    CANCER IMMUNOLOGY RESEARCH, 2015, 3 (03) : 288 - 295
  • [45] Pattern and distribution of BRAF/NRAS and P16CDKN2A mutations among primary an secondary lesions in melanoma patients
    Manca, Antonella
    Colombino, Maria
    Capone, Marilena
    Lissia, Amelia
    Cossu, Antonio
    Rubino, Corrado
    De Giorgi, Vincenzo
    Massi, Daniela
    Fonsatti, Ester
    Staibano, Stefania
    Nappi, Oscar
    Pagani, Elena
    Casula, Milena
    Sini, Maria C.
    Franco, Renato
    Botti, Gerardo
    Caraco, Corrado
    Mozzillo, Nicola
    Ascierto, Paolo A.
    Palmieri, Giuseppe
    CANCER RESEARCH, 2012, 72
  • [46] Melanoma Patients under Vemurafenib: Prospective Follow-Up of Melanocytic Lesions by Digital Dermoscopy
    Perier-Muzet, Marie
    Thomas, Luc
    Poulalhon, Nicolas
    Debarbieux, Sebastien
    Bringuier, Pierre-Paul
    Duru, Gerard
    Depaepe, Lauriane
    Balme, Brigitte
    Dalle, Stephane
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2014, 134 (05) : 1351 - 1358
  • [47] Polyclonality of BRAF mutations in acquired melanocytic nevus and primary melanoma
    Lin, Jingrong
    Takata, Minoru
    Murata, Hiroshi
    Kido, Kenji
    Saida, Toshiaki
    PIGMENT CELL & MELANOMA RESEARCH, 2008, 21 (02) : 318 - 319
  • [48] Polyclonality of BRAF mutations in acquired melanocytic nevus and primary melanoma
    Lin, I.
    Takata, M.
    Murata, H.
    Kido, K.
    Saida, T.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2008, 128 : S216 - S216
  • [49] Clinical Outcome of Melanoma and Atypical Melanocytic Lesions in Children
    Cheesman, E.
    Kelsey, A.
    Brennan, B.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S236 - S237
  • [50] NRAS and BRAF mutations in melanoma-associated nevi and uninvolved nevi
    Tschandl, P.
    Berghoff, A.
    Preusser, M.
    Burgstaller-Muehlbacher, S.
    Pehamberger, H.
    Okamoto, I
    Kittler, H.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 : 41 - 41
12345